Unlocking Opportunities in the Adeno-Associated Viral Vectors Market: Key Trends, Market Growth, and Forecast Insights
2025 Market Reports Update: Market Size Forecasts to 2034, Key Trends, Leading Players, and Top Regions – Get Ahead of the Competition Today!
What Drivers Are Shaping the Growth and Development of theAdeno-Associated Viral Vectors Market?
The adeno-associated viral vectors market is anticipated to expand due to the growing occurrence of genetic disorders. Genetic disorders manifest as physical or developmental abnormalities resulting from DNA aberrations in a person. The rise in genetic disorder cases is attributed to enhanced diagnostic methods, heightened awareness, increased reproductive age, environmental factors, and genetic drift. Adeno-associated viral vectors play a crucial role in the gene therapy of genetic disorders, as they transport corrective genes into the target cells, potentially offering treatments for ailments such as muscular dystrophy or cystic fibrosis. As per the World Health Organization (WHO) in February 2023, congenital diseases resulted in about 240,000 neonate fatalities worldwide within the first 28 days of birth annually. Congenital diseases are also responsible for an additional 170,000 deaths annually among children aged from 1 month to 5 years. Thus, the escalating incidence of genetic disorders is propelling the adeno-associated viral vectors market.
Get Your Free Sample Report Now – Explore Exclusive Market Insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=15969&type=smp
How Will the Growth Rate of theAdeno-Associated Viral Vectors Market Impact Industry Trends by 2034?
The market size for adeno-associated viral vectors has experienced swift growth in the past few years. Projections indicate that it will expand from $2.69 billion in 2024 up to $3.17 billion in 2025, with a compound annual growth rate (CAGR) of 17.9%. The surge seen in the preceding era can be linked to factors such as vaccine creation, amplified funding and investments, collaborations between academics and industry, enlargement of clinical trials, and heightened public awareness and advocacy.
In the upcoming years, the adeno-associated viral vectors market is predicted to witness fast-paced expansion and is estimated to reach $6.08 billion in 2029, with a compound annual growth rate (CAGR) of 17.6%. The growth during this forecast period is expected to be driven by factors such as the increase of therapeutic uses, the rise of genetic and neurological disorders, regulatory endorsements and aid, along with the reduction of production expenses. Principal trends that will influence this market in the estimated period comprise advances in gene therapy, technological breakthroughs, replicable manufacturing methods, cooperation and investments, and further technological development.
You can Directly Purchase the Report Here:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=15969
Which Cutting-Edge Market Trends Are Expected to Drive theAdeno-Associated Viral Vectors Market’s Growth?
Key players in the adeno-associated viral vectors market, like Charles River Laboratories International Inc., are striving to gain a market advantage by ensuring the off-the-shelf availability of replication-capsid plasmid. Rep/Cap plasmids, frequently used in AAV vector production for gene therapy, are conveniently available from a host of commercial sources meeting molecular biology research demands. As an example, in January 2024, the American pharmaceutical firm Charles River Laboratories broadened their product range by introducing off-the-shelf replication-capsid plasmid to boost AAV-based gene therapy endeavors. This new addition aligns well with their current lentiviral packaging and AAV Helper plasmid offerings, reducing manufacturing workload by up to 66%. These ready-for-use plasmids are produced in batches, with rigorous documentation in line with CMC regulations, and they come with a Certificate of Analysis (COA) to aid IND and CTA submissions.
What Are the Leading Market Players Impacting theAdeno-Associated Viral Vectors Market’s Growth Trend?
Major companies operating in the adeno-associated viral vectors market are Pfizer Inc., Astellas Pharma, Biogen Inc., Charles River Laboratories International Inc., BioMarin Pharmaceutical Inc., Sarepta Therapeutics Inc., PTC Therapeutics, Ultragenyx Pharmaceutical, Amicus Therapeutics Inc., Oxford Biomedica, Asklepios BioPharmaceutical Inc., uniQure biopharma B.V., Spark Therapeutics Inc., Akouos inc., Adverum Biotechnologies Inc., Passage Bio Inc., AVROBIO Inc, MeiraGTx Holdings plc, GenSight Biologics S.A., Freeline Therapeutics, Aspa Therapeutics Inc., Adrenas Therapeutics Inc., 4D Molecular Therapeutics, Abeona Therapeutics Inc., Neurophth Therapeutics
Order Your Report Now For A Swift Delivery:
How Are the Key Segments of the Adeno-Associated Viral Vectors Market Driving Opportunities and Innovations?
The adeno-associated viral vectors market covered in this report is segmented –
1) By Type Of Therapy: Gene Augmentation, Immunotherapy, Other Type Of Therapies
2) By Type Of Gene Delivery Method Used: Ex Vivo, In Vivo
3) By Target Therapeutic Area: Genetic Disorders, Hematological Disorders, Infectious Diseases, Metabolic Disorders, Ophthalmic Disorders, Muscle Disorders, Neurological Disorders, Other Target Therapeutic Areas
4) By Scale Of Operation: Preclinical, Clinical, Commercial
5) By Application Area: Gene Therapy, Cell Therapy, Vaccines
Subsegments:
1) By Gene Augmentation: Inherited Genetic Disorders, Muscular Dystrophy, Cystic Fibrosis, Hemophilia
2) By Immunotherapy: Cancer Immunotherapy, Viral Infections Immunotherapy, Autoimmune Diseases Immunotherapy
3) By Other Types Of Therapies: Gene Editing, RNA Therapy, Antiviral Therapy
Gain Exclusive Market Insights—Customize Your Research Report Today for Fast Delivery!
https://www.thebusinessresearchcompany.com/customise?id=15969&type=smp
What Regions Are At the Forefront of #What Drivers Are Shaping the Growth and Development of theAdeno-Associated Viral Vectors Market?# Market Expansion?
North America was the largest region in the adeno-associated viral vectors market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the adeno-associated viral vectors market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
Browse Through More Reports Similar to the Global Adeno-Associated Viral Vectors Market 2025, By The Business Research Company:
The Antiviral & Antimicrobial Coatings Global Market Report 2024
Antiviral Combination Therapy Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antiviral-combination-therapy-global-market-report
Viral Vectors And Plasmid DNA Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
